Assessing the Growing Evidence in Alopecia Areata: The Role of JAK Inhibitors

Assessing the Growing Evidence in Alopecia Areata: The Role of JAK Inhibitors is organized by Med Learning Group.

Program Overview:
This enduring activity discusses the underlying autoimmune causes of alopecia areata (AA) and the rationale of targeted treatment approaches. The burden of AA and its associated comorbidities will also be presented, and you will hear strategies to effectively address the psychosocial impacts of this disease with your patients. Features of this program include whiteboard animations and case studies.

Learning Objectives:
• Explain the autoimmune mechanisms of current and emerging treatments for AA
• Determine which patients with AA are and are not candidates for JAK inhibitors
• Create treatment plans for patients with AA that address the comorbidities and psychosocial impacts of the disease

Additional details will be posted as soon as information is available.